rheumatology
Medicines

Glucosamine products reclassified as “medicines” in UK


Glucosamine products are to be upscheduled as “medicines” instead of “food supplements” in the UK following a legal challenge on prescription status. On 5 September, the Medicines and Healthcare Products Regulatory Agency (MHRA)  announced its decision to upschedule supplements containing 1178 mg/day or above levels of glucosamine as medicines. The move means the makers of glucosamine ...

Already a member?

Login to keep reading.


OR
© 2019 the limbic